CN102517379B - Formula of 96-condition kit for protein crystallization screening - Google Patents

Formula of 96-condition kit for protein crystallization screening Download PDF

Info

Publication number
CN102517379B
CN102517379B CN201110399754.5A CN201110399754A CN102517379B CN 102517379 B CN102517379 B CN 102517379B CN 201110399754 A CN201110399754 A CN 201110399754A CN 102517379 B CN102517379 B CN 102517379B
Authority
CN
China
Prior art keywords
crystallization
condition
formula
screening
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201110399754.5A
Other languages
Chinese (zh)
Other versions
CN102517379A (en
Inventor
尹大川
解思晓
鹿芹芹
刘悦
沈何放
商澎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northwestern Polytechnical University
Original Assignee
Northwestern Polytechnical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northwestern Polytechnical University filed Critical Northwestern Polytechnical University
Priority to CN201110399754.5A priority Critical patent/CN102517379B/en
Publication of CN102517379A publication Critical patent/CN102517379A/en
Application granted granted Critical
Publication of CN102517379B publication Critical patent/CN102517379B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention discloses a formula of a 96-condition kit for protein crystallization screening. The formula contains buffer solutions, salts, precipitants and additives, the types of the precipitants cover all nature compounds, and the formula contains various reagents commonly used for crystallization, so that the success rate of crystallization is enhanced, and the possibility of crystallization is increased; and the anion coverage of the salt matters is comprehensive, the concentration of the precipitants is relatively high, and then, the concentration of a protein sample required in an experiment can be greatly lowered, so that the cost for the experiment is saved, and the formula has a higher value for commercial popularization.

Description

A kind of 96 condition crystallization of protein screening test kit formulas
Technical field
The present invention relates to a kind of 96 condition kits for crystallization of protein screening.
Background technology
At present, the primary screening reagent box of selecting of screening for protein crystallization condition is the Index of Hampton Research company tM96 conditional filtering test kits, concrete composition is in Table 1.
Table 1:Index tMcondition component list
Figure BDA0000116337760000011
Figure BDA0000116337760000021
Figure BDA0000116337760000031
Figure BDA0000116337760000041
Use Index tM18 kinds of protein are carried out to crystallization condition screening study, be respectively cellulase, Chymotrypsin, myohaemoglobin, rnase iii, rnase X II, sweet protein, papoid, Proteinase K, opalescin, N,O-Diacetylmuramidase, chymotrypsinogen, canavalin(e), amylase, stomach en-, cytochrome C, glucophosphatase, oxyphorase, subtilisin, statistics show that its success ratio that grows crystal is only 27.78% (5/18), found that Index tMscreening crystallization condition for most of protein (13/18) is invalid, therefore invents a kind of new efficient screening reagent box very necessary.
Summary of the invention
In order to overcome existing 96 conditional filtering test kits low defect of success ratio in protein crystallization condition screening, the invention provides a kind of new precipitation agent and use more comprehensive 96 condition crystallization of protein screening test kits, can effectively improve protein crystallization condition and be filtered into power.
The technical solution adopted for the present invention to solve the technical problems is: a kind of 96 condition kits of high efficiency protein crystallization condition screening, and called after CU-Index, it specifically forms as table 2.Comprise four parts: damping fluid, salt, precipitation agent and additive.
Table 2:CU-Index 96 condition component lists
Figure BDA0000116337760000042
Figure BDA0000116337760000051
Figure BDA0000116337760000061
The invention has the beneficial effects as follows: 1. the kind of the selected precipitation agent of this test kit covers complete.Its type covers whole nature compounds---inorganics and organism, and comprises all ingredients that crystallization is conventional, thereby has improved the success ratio of crystallization, has increased the possibility of crystallization; 2. in the selected salts substances of this test kit, negatively charged ion covers comprehensively.Inorganic anion and organic anion exist simultaneously, from low valency ion (1), to high valency ion (3), all have related; 3. the selected organism valency of this test kit covers extensively.From low-molecular-weight organic matter (ethanol), to high-molecular-weight organic material (PEG 8000), all have and relate to; 4. this test kit pH scope from 3.5 to 9.5 used, has covered the crystallizable pH of most of protein interval; 5. the relative concentration of the selected precipitation agent of this test kit is higher, thereby in therefore testing, the concentration of desirable proteins quality sample will significantly reduce saving experimental cost, has higher business promotion and is worth.
Embodiment
Preparation CU-Index screening conditions: be example to prepare the condition A2 (0.1M Trisodium Citrate, pH 4.0,0.2M sodiumazide, 10%v/v PEG 8000 and 10%v/v PEG 4000) of 100mL.The first step: compound concentration is 1M, the sodium citrate buffer solution liquid storage of pH4.5; Second step: the sodiumazide liquid storage that the PEG 8000 that compound concentration is 50%w/v and PEG 4000 and concentration are 2M; The 3rd step: mix in beaker with pipette, extract citrate buffer solution liquid storage 10mL, sodiumazide liquid storage 10mL, PEG 8000 and each 20mL of PEG 4000 liquid storages, after being settled to 100mL, use the membrane filtration of 0.22 μ m in clean test tube, the preparation of A2 condition is complete again.Same method is prepared other conditions.
With the crystallization experiment of some protein, verify the effect of this test kit below, with the Index of Hampton Research company tMscreening reagent box in contrast.
Embodiment 1:
By CU-Index 96 conditions of preparation, cellulase (cellulase) is carried out to conditional filtering.Specifically fill a prescription in Table 3.
The CU-Index 96 condition component lists that use in table 3: embodiment 1
Figure BDA0000116337760000091
Figure BDA0000116337760000101
Figure BDA0000116337760000111
Figure BDA0000116337760000121
The first step: the cellulase that is C0615 by the article No. of U.S. Sigma company, being dissolved in pH is 7.0, concentration is in the HEPES sodium damping fluid of 0.025mol/L, is mixed with the cellulase solution that concentration is 10mg/mL, with the filter membrane elimination impurity of 0.22 μ m.
Second step: the present embodiment is used CU-Index 96 conditions of preparation to carry out crystallization condition screening to cellulase.
The 3rd step: use to sit and drip plate, add the pond liquid of 90 μ L in every deep hole, use automatic liquor-transferring system that 1 μ L screening crystallizing agent and 1 μ L protein soln are mixed into crystallization drop, dropping in sits for a while drips in hole, sealing crystallization plates.
The 4th step: above-mentioned crystallization solution system is placed after 6 days in 20 ℃ of temperature control boxs, utilize automatic photomicrograph systematic observation statistics to occur the condition number of cellulase crystal.
Through statistics, obtain result as follows: the crystallization condition number of cellulase is 6, compare its success ratio with Index screening reagent box (crystallization number is 0) and improved without several times, be improved largely.
Embodiment 2:
By CU-Index 96 conditions of preparation, Chymotrypsin (a-chymotrypsin) is carried out to conditional filtering.Specifically fill a prescription in Table 4.
The CU-Index 96 condition component lists that use in table 4: embodiment 2
Figure BDA0000116337760000131
Figure BDA0000116337760000141
Figure BDA0000116337760000151
Figure BDA0000116337760000161
The first step: the Chymotrypsin that is C4129 by the article No. of U.S. Sigma company, being dissolved in pH is 7.0, concentration is in the HEPES sodium damping fluid of 0.025mol/L, and being mixed with concentration is the Chymotrypsin solution of 10mg/mL, with the filter membrane elimination impurity of 0.22 μ m.
Second step: the present embodiment is used CU-Index 96 conditions of preparation to carry out crystallization condition screening to Chymotrypsin.
The 3rd step: use to sit and drip plate, add the pond liquid of 90 μ L in every deep hole, use automatic liquor-transferring system that 1 μ L screening crystallizing agent and 1 μ L protein soln are mixed into crystallization drop, dropping in sits for a while drips in hole, sealing crystallization plates.
The 4th step: above-mentioned crystallization solution system is placed after 6 days in 20 ℃ of temperature control boxs, utilize automatic photomicrograph systematic observation statistics to grow the condition number of Chymotrypsin crystal.
Through statistics, obtain result as follows: the crystallization condition number of Chymotrypsin is 4, compares (crystallization number is 0) its success ratio improved without several times, be improved largely with contrast agents box.
Embodiment 3:
By CU-Index 96 conditions of preparation, myohaemoglobin (myoglobin) is carried out to conditional filtering.Specifically fill a prescription in Table 5.
The CU-Index 96 condition component lists that use in table 5: embodiment 3
Figure BDA0000116337760000162
Figure BDA0000116337760000171
Figure BDA0000116337760000181
Figure BDA0000116337760000191
The first step: the myohaemoglobin that is M0603 by the article No. of U.S. Sigma company, being dissolved in pH is 7.0, concentration is in the HEPES sodium damping fluid of 0.025mol/L, and being mixed with concentration is the myohaemoglobin solution of 10mg/mL, with the filter membrane elimination impurity of 0.22 μ m.
Second step: the present embodiment is used CU-Index 96 conditions of preparation to carry out crystallization condition screening to myohaemoglobin.
The 3rd step: use to sit and drip plate, add the pond liquid of 90 μ L in every deep hole, use automatic liquor-transferring system that 1 μ L screening crystallizing agent and 1 μ L protein soln are mixed into crystallization drop, dropping in sits for a while drips in hole, sealing crystallization plates.
The 4th step: above-mentioned crystallization solution system is placed after 6 days in 20 ℃ of temperature control boxs, utilize automatic photomicrograph systematic observation statistics to grow the condition number of myohaemoglobin crystal.
Through statistics, obtain result as follows: the crystallization condition number of myohaemoglobin is 2, compares (crystallization number is 0) its success ratio improved without several times, be improved largely with contrast agents box.
Embodiment 4:
By CU-Index 96 conditions of preparation, Proteinase K (proteinase K) is carried out to conditional filtering.Specifically fill a prescription in Table 6.
The CU-Index 96 condition component lists that use in table 6: embodiment 4
Figure BDA0000116337760000201
Figure BDA0000116337760000211
Figure BDA0000116337760000231
The first step: the Proteinase K that is P6556 by the article No. of U.S. Sigma company, being dissolved in pH is 7.00, concentration is in 0.025mol/LN-2-hydroxyethyl piperazine-N '-2-ethanesulfonic acid sodium damping fluid, and being mixed with concentration is the Proteinase K solution of 10mg/mL, with the filter membrane elimination impurity of 0.22 μ m.
Second step: the present embodiment is used CU-Index 96 conditions of preparation to carry out crystallization condition screening to Proteinase K.
The 3rd step: use to sit and drip plate, add the pond liquid of 90 μ L in every deep hole, use automatic liquor-transferring system that 1 μ L screening crystallizing agent and 1 μ L protein soln are mixed into crystallization drop, dropping in sits for a while drips in hole, sealing crystallization plates.
The 4th step: above-mentioned crystallization solution system is placed after 6 days in 20 ℃ of temperature control boxs, utilizes automatic photomicrograph systematic observation and counts the condition number of Proteinase K crystal.
Through statistics, obtain result as follows: the crystallization condition number of Proteinase K is 13, compares (crystallization number is 2) its success ratio improved 650% with contrast agents box, is improved largely.
Except the above embodiments, the inventive method is for the screening of 14 kinds of other albumen crystallization conditions, be respectively rnase iii, rnase X II, sweet protein, papoid, opalescin, N,O-Diacetylmuramidase, chymotrypsinogen, canavalin(e), amylase, stomach en-, cytochrome C, glucophosphatase, oxyphorase, subtilisin, it is 66.67% (12/18) that the crystallization of protein obtaining is filtered into power, with Index tMcomparing success ratio significantly improves.

Claims (1)

1. 96 condition crystallization of protein screening test kit formulas, is characterized in that: comprise damping fluid, salt, precipitation agent and additive, shown in concrete table composed as follows
Figure FDA0000116337750000011
Figure FDA0000116337750000021
Figure FDA0000116337750000031
Figure FDA0000116337750000041
CN201110399754.5A 2011-12-05 2011-12-05 Formula of 96-condition kit for protein crystallization screening Expired - Fee Related CN102517379B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110399754.5A CN102517379B (en) 2011-12-05 2011-12-05 Formula of 96-condition kit for protein crystallization screening

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110399754.5A CN102517379B (en) 2011-12-05 2011-12-05 Formula of 96-condition kit for protein crystallization screening

Publications (2)

Publication Number Publication Date
CN102517379A CN102517379A (en) 2012-06-27
CN102517379B true CN102517379B (en) 2014-02-05

Family

ID=46288444

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110399754.5A Expired - Fee Related CN102517379B (en) 2011-12-05 2011-12-05 Formula of 96-condition kit for protein crystallization screening

Country Status (1)

Country Link
CN (1) CN102517379B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103333219A (en) * 2013-04-17 2013-10-02 西北工业大学 Method for selecting buffer solution for protein crystallization
CN103436591B (en) * 2013-08-30 2015-06-10 西北工业大学 Kit for screening protein crystals by taking salt as precipitator
CN111073870A (en) * 2018-10-19 2020-04-28 南京理工大学 Crystallization method of Roc mutant protein
CN109870472A (en) * 2019-01-10 2019-06-11 西北工业大学 Utilize the method for kit formulation screening protein self assembly condition
CN114437165A (en) * 2021-12-22 2022-05-06 厦门医学院 96-condition crystallization screening reagent composition suitable for small-molecule natural product and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101833009A (en) * 2010-04-29 2010-09-15 浙江康特生物科技有限公司 Double antibody complex retinol-binding protein assay kit

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101833009A (en) * 2010-04-29 2010-09-15 浙江康特生物科技有限公司 Double antibody complex retinol-binding protein assay kit

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
刘晶晶等.蛋白质结晶过程的模拟优化和实验研究.《中国优秀硕博论文数据库》.2011,全文.
尹大川等.筛选蛋白质结晶条件的试剂盒研发进展.《生物化学和生物物理进展》.2001,第38卷(第3期),全文.
筛选蛋白质结晶条件的试剂盒研发进展;尹大川等;《生物化学和生物物理进展》;20011231;第38卷(第3期);全文 *
蛋白质结晶过程的模拟优化和实验研究;刘晶晶等;《中国优秀硕博论文数据库》;20110418;全文 *

Also Published As

Publication number Publication date
CN102517379A (en) 2012-06-27

Similar Documents

Publication Publication Date Title
CN102517379B (en) Formula of 96-condition kit for protein crystallization screening
Watanabe Freshwater Culture
Charlton et al. Characterisation of a generic monoclonal antibody harvesting system for adsorption of DNA by depth filters and various membranes
Ammar Cultivation of Microalgae Chlorella vulgaris in Airlift photobioreactor for Biomass Production using commercial NPK Nutrients
CN101817869B (en) Protein crystallization screening 96 condition kit using polyethylene glycol as precipitator
CN105017360B (en) A kind of preparation method of vitamin B12
CN103333219A (en) Method for selecting buffer solution for protein crystallization
CN105413475A (en) Cleaning agent suitable for cleaning hollow fiber nanofiltration membranes and preparation method thereof
AU2003204489A1 (en) Process of extracting nucleic acid and process of simultaneously carrying out extraction and purification of nucleic acid
CN109701499B (en) Nitrogen and phosphorus removal wastewater treatment method
CN102060907B (en) 96 kit for screening protein crystallization
Zhang et al. Occurrence of earthy–musty taste and odors in the Taihu Lake, China: Spatial and seasonal patterns
CN111534509B (en) Composition, reagent, kit and application for deep-sea microorganism in-situ cell lysis
CN1552687A (en) Refining method for long-chain biatomic acid
CN103436591B (en) Kit for screening protein crystals by taking salt as precipitator
CN105566443B (en) Make the method that seed crystal improves crystallization of protein success rate using crosslinked protein crystals
CN114887494B (en) Preparation method and application of metal ion leaching-free release-type MIL-53 modified membrane
CN101320006B (en) Screening method of protein crystallization condition
CN103626259A (en) Immersed type membrane pool and operation method thereof
CN103980110A (en) Combined separation, purification and extraction process for sodium gluconate mother liquor
CN101717759A (en) Method for improving biological macromolecule crystallization condition screening success rate by using drying agent
CN102146369A (en) Coordination based method for extracting DNA (Deoxyribonucleic Acid) with solid-phase medium
CN103254275B (en) Method for increasing success rate of protein crystallization
CN113101889A (en) Iron oxide modified building waste brick particles and preparation method and application thereof
Liu et al. The dual function of impurity in protein crystallization

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140205

Termination date: 20151205

EXPY Termination of patent right or utility model